Rhode Island Hospital joins INSPIRE study as 29th clinical site: 5 points

Cambridge, Mass.-based InVivo Therapeutics added Providence-based Rhode Island Hospital to its INSPIRE study.

Advertisement

Here are five points:

 

1. Rhode Island Hospital represents the 29th INSPIRE clinical site.

 

2. The hospital is the principal teaching hospital of The Warren Alpert Medical School of Brown University.

 

3. Adetokunbo Oyelese, MD, PhD, will serve as principal investigator at the new clinical site.

 

4. Dr. Oyelese serves as director of spinal disorders as well as surgical director for the hospital’s comprehensive spine center.

 

5. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.

 

More articles on devices:
Global SCS devices market to grow at 4.8% CAGR to 2020: 3 key points
Orthofix earns FDA, CE Mark approvals for bone growth stimulators: 6 key points
Expanding Orthopedics reports 100%+ sales growth for FLXfit cage — 5 highlights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.